Global Blood Therapeutics (GBT) is a biopharmaceutical company dedicated to the discovery, development and delivery of life-changing treatments that provide hope to underserved patient communities. Founded in 2011, GBT is delivering on its goal to transform the treatment and care of sickle cell disease (SCD), a lifelong, devastating inherited blood disorder. The company has introduced Oxbryta® (voxelotor), the first FDA-approved treatment that directly inhibits sickle hemoglobin polymerization, the root cause of red blood cell sickling in SCD. GBT is also advancing its pipeline program in SCD with inclacumab, a p-selectin inhibitor in development to address pain crises associated with the disease. In addition, GBT’s drug discovery teams are working on new targets to develop the next generation of treatments for SCD. To learn more, please visit www.gbt.com and follow the company on Twitter @GBT_news.
Location: United States, California, South San Francisco
Employees: 201-500
Total raised: $89.1M
Founded date: 2011
Investors 2
| Date | Name | Website |
| - | Aisling Ca... | aislingcap... |
| - | Perceptive... | perceptive... |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 02.12.2021 | Grant | $400K | - |
| 06.01.2015 | Series B | $48M | - |
| 14.06.2012 | Series A | $40.7M | - |
Mentions in press and media 8
| Date | Title | Description | Source |
| 06.12.2021 | American Express' (AXP) GBT to Go Public at a Valuation of $... | - | entreprene... |
| 29.06.2016 | The biotech IPO feast flags as investors lose their appeti... | There was a time after the 2008 crash that biotech IPOs were about as popular as snow in March. B... | endpts.com... |
| 06.01.2015 | Global Blood Therapeutics Inks $48M Series B | SOUTH SAN FRANCISCO, CA, Biopharmaceutical company developing novel, small molecule therapeutics f... | vcnewsdail... |
| 06.01.2015 | Global Blood Therapeutics Closes $48M Series B Financing | Global Blood Therapeutics (GBT), a South San Francisco, CA-based biopharmaceutical company developin... | finsmes.co... |
| 14.06.2012 | Venture firm launches rare blood disorder therapeutics devel... | Among the company’s founders are three scientific researchers from University of California, San Fra... | medcitynew... |
| 14.06.2012 | Global Blood Therapeutics Launches with $40.7M | SAN FRANCISCO, CA, Third Rock Ventures, LLC today announced the formation of Global Blood Therapeu... | vcnewsdail... |
| 14.06.2012 | Global Blood Therapeutics Raises $40.7M in Series A Financin... | Global Blood Therapeutics, Inc., a San Francisco, CA-based newly formed product-focused company buil... | finsmes.co... |
| - | Venture firm launches rare blood disorder therapeutics devel... | Venture capital firm Third Rock Ventures has launched a drug development startup to treat genetic bl... | medcitynew... |